The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 failed.
Replications
- Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44, Yan et al. (2019). Outcome recorded: failed.
we did not observe changes in tumor growth or CD44 expression; however, unexpectedly miR-34a expression was lost in vivo.
View paper
Other studies in the atlas
Failed replications · Successful replications · All browse pages